Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1976 Jun;3(6):582–585. doi: 10.1128/jcm.3.6.582-585.1976

Combined serotyping and biotyping of Serratia marcescens.

S J Rubin, S Brock, M Chamberland, R W Lyons
PMCID: PMC274359  PMID: 780372

Abstract

The API (Analytab Products, Inc., New York, N.Y.) biotypes of 117 clinical isolates of Serratia marcescens were determined and fell into 13 different patterns. The O and H antigens were determined by tube agglutination, and 27 serotypes were identified. The biotype and serotype appeared to vary indepently. Serotyping and biotyping combined divided these isolates into 56 different types. There was a problem interpreting the end points for inositol fermentation and urease production, which could affect reproducibility of API biotypes. Biotyping is a simple way of screening for possible nosocomial outbreaks of S. marcescens.

Full text

PDF
582

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen S. D., Conger K. B. Serratia marcescens infection of the urinary tract: a nosocomial infection. J Urol. 1969 Apr;101(4):621–623. doi: 10.1016/s0022-5347(17)62391-7. [DOI] [PubMed] [Google Scholar]
  2. Bodey G. P., Rodriguez V., Smith J. P. Serratia sp. infections in cancer patients. Cancer. 1970 Jan;25(1):199–205. doi: 10.1002/1097-0142(197001)25:1<199::aid-cncr2820250128>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  3. Butler D. A., Lobregat C. M., Gavan T. L. Reproducibility of the analytab (API 20E) system. J Clin Microbiol. 1975 Oct;2(4):322–326. doi: 10.1128/jcm.2.4.322-326.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cardos S. F., Florman A. L., Simberkoff M. S., Lanier L. Serratia marcescens: use of detailed characterization of strains to evaluate an increase of isolates in an intensive care unit. Am J Med Sci. 1973 Dec;266(6):447–452. [PubMed] [Google Scholar]
  5. Dodson W. H. Serratia marcescens septicemia. Arch Intern Med. 1968 Feb;121(2):145–150. [PubMed] [Google Scholar]
  6. Dorwart B. B., Abrutyn E., Schumacher H. R. Serratia arthritis. Medical eradication of infection in a patient with rheumatoid arthritis. JAMA. 1973 Sep 24;225(13):1642–1643. doi: 10.1001/jama.225.13.1642. [DOI] [PubMed] [Google Scholar]
  7. Farmer J. J., 3rd Epidemiological differentiation of Serratia marcescens: typing by bacteriocin production. Appl Microbiol. 1972 Feb;23(2):218–225. doi: 10.1128/am.23.2.218-225.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Farmer J. J., 3rd Epidemiological differentiation of Serratia marcescens: typing by bacteriocin sensitivity. Appl Microbiol. 1972 Feb;23(2):226–231. doi: 10.1128/am.23.2.226-231.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hamilton R. L., Brown W. J. Bacteriophage typing of clinically isolated Serratia marcescens. Appl Microbiol. 1972 Dec;24(6):899–906. doi: 10.1128/am.24.6.899-906.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Johnson E., Ellner P. D. Distribution of Serratia species in clinical specimens. Appl Microbiol. 1974 Sep;28(3):513–514. doi: 10.1128/am.28.3.513-514.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rennie R. P., Duncan I. B. Combined biochemical and serological typing of clinical isolates of Klebsiella. Appl Microbiol. 1974 Oct;28(4):534–539. doi: 10.1128/am.28.4.534-539.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sanders C. V., Jr, Luby J. P., Johanson W. G., Jr, Barnett J. A., Sanford J. P. Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak. Ann Intern Med. 1970 Jul;73(1):15–21. doi: 10.7326/0003-4819-73-1-15. [DOI] [PubMed] [Google Scholar]
  13. TAYLOR G., KEANE P. M. Cross-infection with Serratia marcescens. J Clin Pathol. 1962 Mar;15:145–147. doi: 10.1136/jcp.15.2.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Traub W. H., Raymond E. A., Startsman T. S. Bacteriocin (Marcescin) typing of clinical isolates of Serratia marcescens. Appl Microbiol. 1971 May;21(5):837–840. doi: 10.1128/am.21.5.837-840.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wilfert J. N., Barrett F. F., Ewing W. H., Finland M., Kass E. H. Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital. Appl Microbiol. 1970 Feb;19(2):345–352. doi: 10.1128/am.19.2.345-352.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES